Facebook
Twitter
LinkedIn
Forward
This session will review the current state of pharmacology in the treatment of children and adolescents with obesity. Recorded during Overcoming Obesity 2022.
|
Obesity and bariatric surgery are a risk factor for kidney stones and chronic kidney disease.
|
How do you optimize the patient experience, clinic flow and revenue? Let’s get down to the nuts and bolts of what your practice needs to excel.
|
The initial contact with a child with obesity and their family is a critical part of patient care.
|
As published and described in Obesity Pillars (i.e., the official journal of the Obesity Medicine Association), excessive weight reduction is an emerging challenge that sometimes arises with approv
|
OMA 2023 Spring Summit: Overcoming Barriers to Initiating Anti-Obesity Medications (On Demand)CME/CE Expiration Date: 4/23/26
|
Obesity is a disease that disproportionately affects women. Those from ethnic/racial minorities and those who live in poverty are often more severely affected.
|
In this session, speaker will deliver current endocrine society guidelines on gender affirming therapies and the association of obesity with high dose reproductive hormone initiation.
|
A core component of obesity treatment includes recognition of weight promoting medications and their alternatives.
|
Alicia Shelly, MD will discuss the prevalence and etiologies of weight regain after bariatric surgery.
|